0.25
0.5
0.75
1.25
1.5
1.75
2
Intraspinal injection of human mesenchymal stromal cells in SOD1G93A ALS mice
Published on Jul 21, 2017936 Views
Introduction: Cellular therapy is being discussed as novel therapeutic option for the treatment of neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS). Cell therapy for ALS curre
Related categories
Chapter list
Intraspinal injection of human mesenchymal stromal cells in SOD1G93A ALS mice00:00
Cellular therapy00:04
Criteria of the International Society for Cellular Therapy to define MSCs00:45
Isolation of human MSCs01:17
Quality control of MSCs - 101:44
Quality control of MSCs - 202:09
Quality control of MSCs - 302:20
In vitro characterisation of MSCs03:01
In vivo studies of the MSCs03:35
Aims of the in vivo studies03:40
Transgenic ALS mouse model04:02
Intraspinal injection04:10
Behavioural assessments04:41
Intraspinal injection at day 40 - 105:10
Intraspinal injection at day 40 - 205:16
Intraspinal injection at day 40 - 305:38
Intraspinal injection at day 40 - 405:49
Intraspinal injection at day 40 and at day 90 - 105:56
Intraspinal injection at day 40 and at day 90 - 206:03
Intraspinal injection at day 40 and at day 90 - 306:41
Intraspinal injection at day 40 and at day 90 - 406:52
Untitled07:05
Radioactive tracing of MSCs - 207:27
Summary08:03
Outlook08:28
Credits08:50
Thank you for your attention !08:55